Linda S. Lennox
Public Communications Contact chez LANTHEUS HOLDINGS, INC.
Profil
Linda S.
Lennox is currently the Chief of Staff & VP-Corporate Communications at Lantheus Holdings, Inc. Prior to this, she held the position of VP-Investor Relations & Corporate Communications at AMAG Pharmaceuticals, Inc. from 2015 to 2020.
Before that, she was the Vice President-Investor & Media Relations at Critical Therapeutics, Inc. and the Senior Director-Investor Relations at Lantheus Medical Imaging, Inc. Ms. Lennox completed her undergraduate degree at the University of Vermont.
Postes actifs de Linda S. Lennox
| Sociétés | Poste | Début |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01/08/2020 |
Anciens postes connus de Linda S. Lennox
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Investor Relations Contact | 01/07/2020 |
| Critical Therapeutics, Inc. | Public Communications Contact | 04/11/2008 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Investor Relations Contact | - |
Formation de Linda S. Lennox
| University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
